Synthesis of carboxymethyl Xanthan/ double-walled carbon nanotube hybrid hydrogel nanocomposite for transdermal release of drug
Source abstract
Abstract
The inclusion of double-walled carbon nanotubes in carboxymethyl xanthan-based hydrogels was developed in order to improve both mechanical and drug release (diclofenac) properties of these nanocomposites for potential application in the biomedical field. The synthesis of carboxymethyl xanthan was carried out by an esterification reaction between xanthan gum and monochloroacetic acid, and the grafting was confirmed by FTIR analysis. The obtained carboxymethyl derivatives exhibited higher hydrophilicity degrees of substitution compared to the native xanthan gum. The nanocomposites prepared using either raw or modified xanthan gum were characterized in terms of physical properties, and we evidenced both an increase in viscoelasticity by one order of magnitude and an improved distribution of the nanotubes within the hydrogel matrix in the case of the carboxymethyl xanthan. The trapping efficiency of diclofenac was improved by the addition of the nanotubes, reaching up to 74 wt %. While the nanotubes also allowed a slower release of the molecule. An in-vitro study was carried out to ensure that the CNTs grafted onto the modified CMX were not released during the diffusion of the active ingredient.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Hydrogels: synthesis, properties, applications · Advancements in Transdermal Drug Delivery · Polysaccharides Composition and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Chemical Engineering Laboratory, Process Engineering Department, Faculty of Technology, University of Blida, 1 Soumaa, Blida, Algeria
Functional Analysis of Chemical Processes Laboratory, process Engineering Department, Faculty of Technology, University of Blida, 1 Soumaa, Blida, Algeria
Interuniversity Center for Research and Engineering of Materials, Université Paul Sabatier, Toulouse, France
References (51)
Show source-provided references
1. 10.1155/2014/82501710.1155/2014/825017 ↗
2. 10.1080/1061186080245581310.1080/10611860802455813 ↗
3. Giria A. · Int. J. Biol. Macromol. · 2011 · 49 · 88510.1016/j.ijbiomac.2011.08.003 ↗
4. 10.1039/C1CS15203C10.1039/C1CS15203C ↗
5. 10.1021/cr000108x10.1021/cr000108x ↗
6. 10.1039/b210140h10.1039/b210140h ↗
7. Jen A. C. · Biotechnol. Bioeng. · 1996 · 50 · 35710.1002/(SICI)1097-0290(19960520)50:4<357::AID-BIT2>3.0.CO;2-K ↗
8. 10.1016/j.mtchem.2018.02.00410.1016/j.mtchem.2018.02.004 ↗
9. 10.1016/j.polymer.2008.01.02710.1016/j.polymer.2008.01.027 ↗
10. 10.1016/j.addr.2012.09.01010.1016/j.addr.2012.09.010 ↗
11. Kamouna E. A. · Arabian J. Chem. · 2015 · 8 · 110.1016/j.arabjc.2014.07.005 ↗
12. 10.1002/adma.20080210610.1002/adma.200802106 ↗
13. 10.1016/j.jconrel.2013.10.01710.1016/j.jconrel.2013.10.017 ↗
14. Gaharwar A. K. · Biotechnol. Bioeng. · 2014 · 111 · 44110.1002/bit.25160 ↗
15. 10.1007/s11095-008-9811-010.1007/s11095-008-9811-0 ↗
16. Yang L. · Adv. Drug Delivery Rev. · 2011 · 63 · 136110.1016/j.addr.2011.10.002 ↗
17. Flahaut E. · Chem. Commun. · 2003 · 144210.1039/b301514a ↗
18. 10.1016/j.compositesb.2015.05.03810.1016/j.compositesb.2015.05.038 ↗
19. Arash B. · Sci. Rep. · 2013 · 3 · 178210.1038/srep01782 ↗
20. Ménard-Moyon, C. Applications of Carbon Nanotubes in the Biomedical Field, in Smart Nanoparticles for Biomedicine; The Netherlands: Elsevier, 2018; pp 83–101.10.1016/B978-0-12-814156-4.00006-9 ↗
21. Bellingeri R. · J. Appl. Polym. Sci. · 2015 · 13210.1002/app.41370 ↗
22. 10.1038/381678a010.1038/381678a0 ↗
23. 10.1016/j.compscitech.2011.10.00210.1016/j.compscitech.2011.10.002 ↗
24. 10.3390/ma1204062410.3390/ma12040624 ↗
25. Ghedjatti A. · ACS Nano · 2017 · 11 · 484010.1021/acsnano.7b01328 ↗
26. Li H. · Colloids Surf. B · 2004 · 33 · 8510.1016/j.colsurfb.2003.08.014 ↗
27. Erlanger B. F. · Nano Lett. · 2001 · 1 · 46510.1021/nl015570r ↗
28. 10.1002/(SICI)1521-3773(19990712)38:13/14<1912::AID-ANIE1912>3.0.CO;2-210.1002/(SICI)1521-3773(19990712)38:13/14<1912::AID-ANIE1912>3.0.CO;2-2 ↗
29. 10.1385/JMN:14:3:17510.1385/JMN:14:3:175 ↗
30. Foldvari M. · Biol. Med · 2008 · 4 · 183
31. 10.1016/j.drudis.2010.04.00510.1016/j.drudis.2010.04.005 ↗
32. Servant A. · Adv. Healthcare Mater. · 2013 · 2 · 80610.1002/adhm.201200193 ↗
33. 10.1039/c3tb20614a10.1039/c3tb20614a ↗
34. 10.1002/cphc.20170051710.1002/cphc.201700517 ↗
35. 10.1016/j.bbamem.2005.10.00810.1016/j.bbamem.2005.10.008 ↗
36. 10.1021/nn700040t10.1021/nn700040t ↗
37. maedaH B. · Polymericdrugsforefficient Tumor targeteddrugdeliverybasedonEPR Effect · 2009 · 71 · 409
38. García-Hevia L. · Adv. Healthcare Mater. · 2015 · 4 · 164010.1002/adhm.201500252 ↗
39. Magnette J. · European Journal of Dermatology : EJD · 2004 · 14 · 238
40. 10.12968/bjcn.2006.11.11.2227810.12968/bjcn.2006.11.11.22278 ↗
41. Leong K. H. · Carbohydr. Polym. · 2011 · 83 · 150710.1016/j.carbpol.2010.09.062 ↗
42. 10.1016/j.carbpol.2016.06.08010.1016/j.carbpol.2016.06.080 ↗
43. Flahaut E. · J. Mater. Chem. · 2004 · 14 · 64610.1039/b312367g ↗
44. 10.14227/DT180311P1510.14227/DT180311P15 ↗
45. 10.1016/j.ijbiomac.2012.08.02310.1016/j.ijbiomac.2012.08.023 ↗
46. 10.1016/j.ijbiomac.2014.04.03610.1016/j.ijbiomac.2014.04.036 ↗
47. Mendes A. C. · Macromol. Biosci. · 2012 · 12 · 35010.1002/mabi.201100304 ↗
48. 10.1016/j.carbon.2014.06.05110.1016/j.carbon.2014.06.051 ↗
49. 10.1021/ja053003q10.1021/ja053003q ↗
50. 10.1002/app.3309510.1002/app.33095 ↗
51. 10.1016/j.colcom.2017.11.00710.1016/j.colcom.2017.11.007 ↗